Eli Lilly welcomes you to a specialized educational session with globally recognized endocrinology experts Prof. Eva Lau, Prof. Matthias Blüher, Prof. João Sérgio Soares Neves, and Prof. Serena Tonstad.
In this session, the experts will explore the mechanism of action of tirzepatide (Mounjaro®), a GIP and GLP-1 receptor agonist, review key principles of incretin physiology and pharmacology, and highlight clinical findings that underscore the potential of tirzepatide in addressing obesity. Join us on February 20 , 2026 , from 6:00 PM to 7:00 PM IST , and enhance your obesity management strategies with current real-world evidence. We look forward to an engaging and insightful discussion with you. Agenda : Abbreviations : GIP: Gastric inhibitory polypeptide; GLP-1 RA: Glucagon-like peptide-1 receptor agonist Click here to view Mounjaro API . Therapeutic indication Type 2 diabetes mellitus…
